Literature DB >> 23903003

Mosaic segmentation, COPD and CHF multimorbidity and hospital admission costs: a clinical linkage study.

Lucy Doos1, John Uttley2, Ifeoma Onyia3, Zafar Iqbal3, Peter W Jones1, Umesh T Kadam1.   

Abstract

BACKGROUND: How multimorbidity and socio-economic factors influence healthcare costs is unknown. Geo-demographic profiling system, Mosaic, which adds to socio-economic factors, provides the potential for an investigation of the relationship with multimorbidity, and their influence on healthcare costs.
METHODS: Using chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) registers from 53 general practices for a population aged 40 years and over in Stoke-on-Trent, England (N = 10,113), were linked to hospital admissions data and Healthcare Resource Groups as a measure of hospital cost (2007-09). Eleven Mosaic groups were linked on the basis of individual patients' post codes.
RESULTS: The COPD and CHF multimorbid group (n = 763) had the highest proportion with at least one hospital admission in the 3-year time period (n = 550, 72%), compared with the index COPD (56%) and CHF (66%) groups. Multimorbid patients had significantly higher mean costs for hospital admission (£4896) compared with the index COPD (£2769) or CHF (£3876). The associations between multimorbid groups and hospital admission costs compared with index groups varied by different Mosaic groups.
CONCLUSIONS: CHF and COPD multimorbidity is associated with high costs, and average hospital admission costs vary by Mosaic segmentation. Multimorbidity and Mosaic provide an innovative basis for developing and targeting healthcare interventions in high-hospital-cost patients.
© The Author 2013. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Mosaic; healthcare costs; heart failure; multimorbidity; obstructive lung disease; organization and administration

Mesh:

Year:  2013        PMID: 23903003     DOI: 10.1093/pubmed/fdt070

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  4 in total

Review 1.  Managing comorbidities in COPD.

Authors:  Georgios Hillas; Fotis Perlikos; Ioanna Tsiligianni; Nikolaos Tzanakis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-07

2.  Assessing the potential utility of commercial 'big data' for health research: Enhancing small-area deprivation measures with Experian™ Mosaic groups.

Authors:  Welcome M Wami; Ruth Dundas; Oarabile R Molaodi; Mette Tranter; Alastair H Leyland; Srinivasa Vittal Katikireddi
Journal:  Health Place       Date:  2019-05-21       Impact factor: 4.078

Review 3.  Participation in lung cancer screening.

Authors:  David R Baldwin; Kate Brain; Samantha Quaife
Journal:  Transl Lung Cancer Res       Date:  2021-02

4.  Does geodemographic segmentation explain differences in route of cancer diagnosis above and beyond person-level sociodemographic variables?

Authors:  C J Bright; C Gildea; J Lai; L Elliss-Brookes; G Lyratzopoulos
Journal:  J Public Health (Oxf)       Date:  2021-12-10       Impact factor: 2.341

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.